Startup Entrants outline

AusAir Essentials has created the world’s first anti-pollution mask with unique health benefits. Our mask is comprised of two components, a stylish reusable outer skin, and replaceable woollen filters. The reusable component of the mask comes in a range of different designer patterns and block colours, making our mask not only functional, but fashionable. Our filter range is called ‘Air+’ as each filter contains an organic plant compound, benefiting the user’s health. We have three filters in our botanical range: ‘Tea Tree Skin’, ‘Eucalyptus Clear’, and ‘Lavender Serenity’. We also have the option for a blank filter. Our mask not only solves the problem of air pollution, but goes beyond by solving both the problems present in current mask designs, as well as health and wellbeing problems. Our mask will address the pollution problems by meeting Australia and New Zealand respiratory protection standards (AS/NZS 1716). This means it filters out 94% of particulate matter between 0.02 to 2 microns, providing an extremely high level of respiratory protection to the user.

Head of Marketing

Nominated by

Entrepreneurship Programs Manager,
University of Sydney Business School
AusAir entered the Sydney Genesis start-up program (The University of Sydney) in March 2018 and were awarded the prize for ‘Best Scalable Business in Asia. Throughout the program, AusAir have demonstrated a high level of commitment to their company’s vision, a high level of creativity and innovation across their product range, and uniqueness in the category of aesthetic face masks. Given that the start-up’s target market is focused in Asia, we believe that AusAir are a well-suited candidate to compete in the Asia Entrepreneurship Awards.

Spark Eyewear’s VISFIT technology is the world’s first solution which provides real time face scan, custom eyewear design and digital manufacturing. VISFIT extracts facial features using deep learning vision technology, and accordingly generates an optimal custom eyewear using a proprietary parametric eyewear computing engine, which is vision-centered and provides the best fitting experience. The custom eyewear is 3D printed on Visfit 3D printing cloud and post-processed with fine finishing technics, which offers a unique optometric and wearing experience.


Nominated by

Director of Lab,
Tsinghua University
The vision problem worldwide is worsening every year as people are spending more time on electronic devices. As a result, more than 3 billion people need eyecare but a significant portion of which are lack of proper visioin assistance. Visfit’s cutting edge AI technology empowers the eyewear industry to customize every frame to best fit customer’s face with optimal optometric and wearing experience.Visfit aims to solve the problem of 200 million people who are not comfortable with light and wear uncomfortable glasses. It is the new ecological entrance for digital glasses in the future.

Modular robotics is one of the most complex areas of robotics. Each added element allows new movements. Normally such robot stays in research labs, in places like MIT and Carnegie Mellon. We invented CellRobot which gives access to such cutting edge technology to non-specialists.
Cellrobot is the first complete consumer modular robotics kit which can be assembled in hundreds of different combinations to perform any task. Traditional Lego liked robots has thousands of building blocks, it’s takes hours for a child to build one robot, it’s really hard for them to create. CellRobot system replace these blocks with one smart and powerful Cell. Bring a perfect platform for children to create.

Founder & CEO

Nominated by

Senior Manager,
Beijing Innoway Technology Services Co., Ltd.
Cellrobot is the first complete consumer modular robotics kit which can be assembled in hundreds of different combinations to perform any task. Traditional Lego liked robots has thousands of building blocks, it’s takes hours for a child to build one robot, it’s really hard for them to create. CellRobot system replace these blocks with one smart and powerful Cell. Bring a perfect platform for children to create.

Through independent research and development of equipment, processes and systems, the company can produce high-quality silicon nano-particle products with small particle size, uniform and controllable, high sphericity and purity, nano-material dispersion through silicon powder. And silicon carbon coating technology, can be used in the negative electrode of lithium battery to greatly improve the energy flow density of the lithium battery, that is, greatly improve the endurance of the lithium battery to enhance the mass per unit volume.
Lithium batteries are widely used in mobile phones, computers, electric vehicles and other fields. They have a very broad application prospect. The market capacity is 100 billion. The project aims to improve the application capacity of lithium batteries and greatly enhance the market demand and customer experience. Solve the pain point of lithium battery in the application is not stable enough and endurance is insufficient.


Nominated by

Chief Executive,
High-quality silicon nanoparticles produced by Gexin New Energy, with small particles (minimum 2nm), controllable size (2-100nm optional), narrow particle size distribution (deviation S<3), high sphericity (100% sphericity) ), the crystal form is adjustable, the purity is extremely high (greater than 99.999%) and other six obvious advantages. When the high-quality silicon nanoparticles are added to the negative electrode of the battery, the energy density of the battery is greatly increased, and high stable cycle performance can be maintained. The company has in-depth research on the use of silicon nanoparticles for lithium battery anode technology. At present, the addition amount can reach 40%, which is much higher than 5%-10% on the market, which can improve the specific capacity of lithium battery anode materials and prolong battery life.

At present, India requires better and affordable health care products for aggressive diseases like cancer. Currently, millions of Indian patients do not have access to right health care products, as they are not available in India. Majority of the hospitals in India still depend on the Western technologies that are not accessible.
With the new Make-in-India initiative introduced by our current Prime Minister, Diagnostring Laboratories believed to be a first Indian company to innovate and develop cancer and genomics based health care and diagnostic products.

Chief Executive Officer

Nominated by

Executive Director,
The objective of Diagnostring is to innovate the healthcare technology through the novel genòmics (DNA) platform and provide easy and affordable solutions to clínic and save lives of people affected by cancer. For this purpose, Diagnostring have put together a team of genomics and biotech experts along with clinicians to develop patented products that could be catered to patients outside India.
Diagnostring is incorporated in India as privately funded and limited company. The company has about 5 full-time employees with a mission of expanding over time. Diagnostring has cutting-edge and necessary equipment such that they are completely operational within less than 2 years that is not possible for most of the startups in India. Overall, Diagnostring’s mission is to treat patients based on their DNA profiles such that personalized treatment would be made possible for càncer patients. Since only a fraction of Indian patients have access to càncer healthcare products, their innovative technology and methods would help them to increase the revenue of the company.

Onward Assist is a machine learning platform focused on oncology, that provides decision assistant tools across the clinical process – including Diagnostics as well as treatment decision assistance. Onward Assist provides Oncology analytics tools that help clinicians be able to look at information of a large volume of patients and come to accurate clinical diagnosis and diagnosis. These analytics tools are built for Histopathologists (Microscopic examination of the Tissue), Radiologists (Medical Imaging such as X-rays) and Oncologists.
The key focus today is in diagnostics assistance in Radiology, and Computational pathology (around Breast càncer and Cervical cancer). Their tools does the work of a radiologist and pathologist respectively, and helps improve productivity by 30-40% (reflected by the reduction in the time taken to complete the reporting of an image, or a slide).
Onward Health is run by CoFounders, Dinesh Koka and Vikas Ramachandra who bring a combined 30+ years of experience in Healthcare, Business Development, Computer Vision, and Deep Tech. Dinesh is a 16+ years Healthcare Industry Exec, having worked with GE Healthcare, and then startups. Vikas Ramachandra (Ph.D) heads Data Science, and brings 10+ years of deep expertise across computer vision, machine learning having worked with Qualcomm and healthcare analytics startups in the US.


Nominated by

Zone Startups
Onward Health is in the Intersection of AI and Health care both focus areas of AEA 2018; bringing in Intelligence based on data to the clinical process (especially Oncology).They address a real problem (Cancer diagnostics), with a real solution that has crossed the Proof of validation stage. A great team of co-founders with over 25 years of experience; they have made good early stage decisions to focus on bigger Longer term revenue as opposed to smaller immediate revenue. They are early enough in the product /solution lifecycle to benefit well from AEA/Japan’s ecosystem. Besides the problem and their solution are essentially Global problems and fall in the range of Suggestive AI Solutions; an area which fits well within the regulatory framework of Global regulators like FDA (USA) and PMDA (Japan). Unlike other areas AI/Healthcare start-ups are characterized by much longer sales/product lifecycles and take longer to get to market, need deeper founder expertise, prior customer/partner knowledge; since AEA’s focus in 2018 is in these areas the nomination. Before choosing Onward Assist I looked at atleast 30 start-ups among multiple Indian Start-up ecosystems in multiple cities.

Plant disease reduces the yield quality and quantity globally. Each year, 20% to 40% of total global crops production is lost because of pest and plant diseases in important crops such as maize, potato, and tomato. According to our survey, the majority of farmers diagnose plant diseases using their own assumption which makes it not accountable and not accurate enough. Technology solution could be the answer to the problem.
We develop Dr. Tania, a chatbot based mobile application that could help farmers to diagnose and manage plant diseases. The user could interact with Dr. Tania using daily language so the user can use the apps easily. The only thing a user needs to do is to take a picture of plant, upload it through Dr. Tania, and she/he will get quick plant disease diagnosis alongside recommended treatments and related products. Powered by Deep Learning, Dr. Tania presents a clear path towards smartphone-assisted crop disease diagnosis on a massive global scale. It could be integrated with satellite imagery, drone, IoT, e-Commerce, etc. Dr. Tania is projected will pass the turnover at the end of 2018 with ROI at 2019 reach 64%. It shows that this business is not just impactful, but also sustainable.


Nominated by

Coordinating Ministry for Economic Affairs (CMEA)
Being in the early years of its establishment, in my opinion, Neurafarm is rather idiosyncratic in the kind of solution it tries to bring to market. Artificial intelligent (AI) technology in combination with ample knowledge in precision farming as can be seen in team members’ qualification, were thoughtfully catered to become the key technology of their solution at one side. At the other side, the niche market Neurafarm intends to occupy, i.e. farmers exist in large number domestically and even Globally. These alone provide market expansion opportunity in the future. Moreover, besides smallholder farmers that were currently chosen as main market, in the future Neurafarm can direct more efforts to check the opportunity with even larger plantations like palm oil, rubber, coffee, tea, cacao etc. in the Global sphere. Surely, additional technology like aerial photography, chromatography, Internet of Things (IoT) etc. should be considered to equip their solution to suit the more advanced market or perhaps to contribute toward the establishment of smart plantation. In the short that I understand, a solution of this kind is rather new to me. In so doing, in my view, Neurafarm has a bright chance to success.

As laparoscopic surgery needs three doctors, the number of operations and the surgical procedure are often limited because of lack of doctors. Although current surgical robot seems to be performing surgery by one doctor, the number of doctors is not reduced because other doctors are necessary to assist robot procedure. We propose a new robot that cooperatively operates with a surgeon. Our robot can replace both a scopist and an assistant, and can be controlled by handheld tools which is commonly used in laparoscopic surgery. As this concept enables direct control of assistants while the surgeon is operating normal procedure, the surgeon can operate surgery as they want anytime. Furthermore, as conventional laparoscopic surgery can be operated by only one surgeon, many of surgery can be operated even if the hospital doesn’t have enough doctors.


Nominated by

MedVenture Partners, Inc.
A-Traction is the first startup from Japan that is developing a truly needs based robotic-assisted surgical system. They have teamed up with the National Cancer Center Hospital East to develop an innovative system that aims to take the cutting-edge TaTME procedure for colorectal cancer and make it into a much more easily performable and highly successful procedure. The A-Traction system will allow the TaTME procedure to be performed at hospitals across Japan and therefore directly impact the QOL of colorectal cancer patients all over the country.
A-Traction is comprised of a team of highly experienced engineers that are dedicated to changing the landscape of the medical field in Japan. They have taken what was just an idea 3 years ago and made it into a fully functioning prototype. Their system is not limited to only the TaTME procedure, but it can also be used in a multitude of other general surgery procedures and will try to transform how surgeries are performed in Japan and throughout the world.

Our core product is an AI based operation room (OR) management system for hospitals.
Hospitals have been suffering from degradation of management, declines in quality of life (QOL) for doctors and nurses due to long working hours. Also, because of inefficiencies in the workflow process around OR, we can see an increase in patient waiting time.
Our AI platform can optimize the schedule of surgeries and staff by allocating each intervention to its appropriate time slot, reducing overtime and inherently minimizing the waiting time for the patient.
The reason why we have focused on operating rooms is because 70% of revenues and 40% of hospital’s costs in Japan come from the OR, which means OR are at the centre of hospital’s management.
To our knowledge, there are no companies within Japan that offer a similar product or service. However, IT companies such as Fujitsu, NEC and others, do offer traditional OR management systems. We have adopted a monthly subscription model to our SaaS offering. Already, we have early adopter and a paying customers. As a next step in our strategy, we plan to forge an alliance with a nationwide medical distributor, in order to expand our product all over Japan.


Nominated by

Assistant Manager,
TOHOKU University Venture Partners Co., Ltd.
There are 3 reasons for attending AEA.
1, I think that AEA will be one of the best places for them to make their company known.
2, Their goal is to expand the business to other countries in the Asian region, and I believe that AEA could be that launching platform for them.
3, They have already forged alliances with the academia and they are in the process of joint development and sales with already established companies in the industry.
Therefore, I would like to accelerate their development process and make their product more sophisticated by establishing new alliances.
AEA will be a great opportunity for them to further validate their business ideas and to form new partnerships.

Girasol Energy Inc. was founded in February, 2017 based on the power line communication technology invented by Dr. Hideya Ochiai, Associate Professor at the University of Tokyo. The company provides IoT platform for the solar power plants. By using patented power line communication technologies, the company enables the power plant operators to monitor the solar panel modules remotely. Monitoring of solar panel modules is a big problem for the solar power plant operators since the degradation of a single solar panel among hundreds of panels causes significant performance loss of the entire PV system. By installing a simple IoT sensor to each PV(Photovoltaic) panel, power plant operators can gather data from hundreds of sensors over the power line without installing any extra communication lines or additional nodes. Data from IoT sensors are collected at a gateway unit and then sent directly to the cloud platform. By using PPLC system, solar power plant operators can monitor the performance of each panel remotely in real time and can detect the degradation of a PV panel automatically. The maintenance cost of solar power plants will be reduced significantly by using the company’s platform.


Nominated by

Project Professor,
The University of Tokyo
Girasol Energy Inc. provides PPLC platform, an IoT platform for the solar power plants based on the power line communication technology developed by Dr. Hideya Ochiai, Associate Professor at the University of Tokyo. The patented technology is unique in transmitting data from PV panels over noisy power line without installing any additional devices or communication line. By providing PPLC platform, the company enables solar power plant operators to monitor the performance of each solar panel and to detect the degradation of each PV panel. The company’s PPLC IoT platform can significantly reduce the maintenance cost of the solar plant operators and improve the profitability of solar power generation businesses. The social impact of making the solar power generation business profitable and sustainable is very large.

PLIMES Inc. is a university spin-off company launched to create a pathway to market for academic research innovations originating from the research achievements at the Artificial Intelligence Laboratory, Center for Cybernics Research and Center for Innovative Medicine and Engineering at the University of Tsukuba, Japan.
PLIMES Inc. is managed by the cofounders Kenji Suzuki, PhD(Eng.), Tomoya Shimokakimoto, PhD(Eng.) and MSc (Med. Sc.), Dushyantha Jayatilake, PhD(Eng.) who each have over 15 years of experience in developing healthcare/robotics technologies and Atsushi Nitasaka (CEO of ZINE), who has experience in launching successful startups and the know-how to reach out using modern media strategies. In addition, we have a comprehensive board of medical advisors to accurately shape the technology to match the need. We are social enablers and PLIMES Inc. focuses on the social problem-solving business by operating to dramatically enhance user experience and social interaction for people with special needs. We spent over 10 years in the academia developing these fundamental technologies that are finally ready to be transferred to the society.

CTO & Co-founder

Nominated by

Professor, University of Tsukuba,
Deputy Director for International Industry University Collaborative Headquarter
As a model case using the intellectual property of the University of Tsukuba, it is a venture company that established a company by using faculty members themselves for their research results and is rapidly growing. Swallowing measurement technology utilizing artificial intelligence technology / robotics technology has gained high evaluation and is a technology contributing to the quality of life of mankind. Since it is an important technology supporting the future of the Japanese health industry, we hope to make a big leap and strongly recommend it.

Value and Trust Co., Ltd.(hereafter VNTC) develops solutions to maintain the correct shape of the spine. Our main product is spine correction brace, Spinamic, but we also develop advanced diagnostic and prescription system to help produce more sophisticated devices. Our focus at the moment is on teenage patients with scoliosis(AIS) and we aim to ensure that children with scoliosis maintain the correct shape of spine without surgery.
Our product, Spinamic, is a fabric type scoliosis brace, which is easy to wear and washable, thus more hygienic. Through our brace, we can treat AIS(adolescent idiopathic scoliosis) patients the most effective way with minimized side effects that existing rigid braces have failed to deal with. Our focus is to improve the quality of life of the scoliosis patients without side effects, especially depression. We are now preparing to develop and apply our product and system to various vertebral deformities.
For our goal of improving patients’ quality of life, VNTC works with many spinal experts including spinal mechanic engineers, doctors, product designers, and textile experts.


Nominated by

School of Business Administration, Kyungpook National University
I recommend Value & Trust company as a team representing Korean startup for AEA 2018 event since it creates both economic and social value by introducing high tech and hygiene spine correcting device. The company's business model is pretty solid, and it has great social impacts on helping children with scooped spine problems without having side effects. The company has made good use of its network with hospitals, and has a well-designed marketing strategy for expanding the share of domestic and overseas markets. Clearly separated from competitors' products in terms of its weight, comfort and cleanness, it is highly competitive, and at the same time, reduces the stress levels of children who wear it, making them less nervous. It uses a fabric type scoliosis brace. CEO, researchers and administrative support team members are filled with a sense of mutual cooperation. CEO, who has an egalitarian philosophy, facilitates candid communication within the company, which facilitates company's quick adaptation to market and technology changes. In sum, the company is expected to be prospering in a great scale.

DF Automation & Robotics Sdn Bhd is one of the leading robotic company in South East Asia. DF designs and manufactures Automated Guided Vehicle (AGV). AGV is an industrial mobile robot that can move autonomously from one point to another and very useful to carry heavy loads. This is very useful for manufacturing industries as they can reduce labor reliance and increase efficiency. The mobile robotics market worldwide is USD$8.58bn in 2016 and expect to grow to US$30bn by 2025. DF envisions to be one of the leading player in industry mobile robot. DF has developed many patent pending products including Zalpha AGV, Titan AGV, Suki AGV as well as our in-house developed software, NavWiz. NavWiz is an easy to use software to program the AGVs and with IoT enabled feature. DF has sold to many MNC companies includes Sony, Toto, Yamaha, Produa, Jabil, Sanmina, Flex, among others and has exported to Singapore, Thailand, India, Indonesia, Vietnam, Philipines, Mexico, US and UK.


Nominated by

Manager of Business Development,
Putra Business School
• DF is a fast growing robotic company in Malaysia and has exported to SG, Thailand, Philippines, Indonesia, India, Mexico, US and UK.
• With the industry 4.0 waves, the needs of robotics is escalating in this region.
• DF has designed many products with at least one new product every 6 months such as NavWiz, Zalpha, Titan, Suki, etc.
• DF has several patents pending, industry designs and trademarks.
• DF total revenue growth year to year is at least 100% since 2015.
• The team is founded and operated by a rare combination of lecturer and students and they have young team of average age of 27.
• DF vision is to be the leading robotic company in Asia if not the world.
• DF has won several international awards including from Frost & Sullivan and APICTA.

The grocery retail market is globally worth $10 trillion. The experience economy is demanding that retailers consider innovation in the physical space to meet increasing consumer expectations, and the brands that embrace this reality will see unprecedented growth. IMAGR is a technology and experience innovation that will transform the retail experience forever. 90% of all retail transactions today are done via bricks and mortar, which shows that retail isn’t dead, and with the increasing investment made by e-commerce giants into this space, the incumbents must act now to ensure they survive.

Founder & CEO

Nominated by

Investment Manager,
New Zealand Trade and Enterprise
NZTE is impressed with Imagr’s entrepreneurial ambition and ability to pull together a deep tech offering which will compete globally against the likes of AmazonGo, therefore reducing the pain point of retail queuing.

The Brain Beat Glucometer (BBG) is the blood glucose non-invasive self-monitoring device for Diabetes Mellitus sufferers. Unlike the traditional methods of monitoring blood glucose, BBG causes absolutely no pain or discomfort to the user and will immeasurably improve the quality of life of diabetic patients. It also offers significant cost savings by eliminating the need for expensive consumables, which cost the average diabetic approximately €3,118 per annum.
Brain Beat team has over 50 years cumulated research experience in the fields of biophysics, high performance computing and medicine, and over 32 years experience creating, growing and managing successful start-ups and companies in biotech industry. The company has developed a pre-production prototype and holds negotiations with large medical device manufacturers on licensing the technology to them for manufacturing and distribution of the device through their own established networks. Discussions are underway with potential key stakeholders such as LifeScan, Abbott and LG.


Nominated by

International Projects Manager,
Skolkovo Foundation
Brain Beat represents a successful technology transfer of the spectroscopic technologies and the absorption spectra of glucose, which are both well known in the scientific community, to the global market. The solution of non-invasive glucometry, provided by the company, has a tremendous social impact: its implementation will drastically increase quality of life of more than 430 million diabetics around the world, helping them to control glucose level 24 hour a day. The company’s team has a solid experience both in science and business development. Moreover, CEO of the company is familiar with the Japanese business culture and has certain level of command of the Japanese language, which will definitely be of use in establishing and maintaining relationship with potential Japanese partners.

ProSpace is a B2B Proptech start-up that provides a unique and powerful analytics solution (incorporating both hardware & proprietary software) for MNCs to quickly and easily strategize and optimize their workplace portfolio globally. We specialize in creating a time-series Activity Map of their employees working in their offices as well as other office spaces. This map (created without compromising the privacy of staff) and our analytics – allow companies to leverage activity data to plan and design office space. This significantly reduces costs and shortens planning cycles, while boosting the quality and productivity of corporate real estate & facilities organisations.

ProSpace is in early stage market expansion outside Singapore. Since launching our MVP platform in 1st Quarter 2017, ProSpace has successfully secured many reputable clients such as Procter & Gamble, Unilever, Temasek Investment, Rio Tinto, Capitaland and others. Our clients are located in Singapore, China and Japan.
ProSpace is headquartered in Singapore and have satellite offices in Indonesia and China.


Nominated by

National University of Singapore
Since it’s founding in 2015, ProSpace has made good progress :
• product offerings – through constant R&D and technology improvements
• market access – moving beyond Singapore to venture into markets like China and Japan
• team and human resource - growing a strong team with good capabilities and leveraging lower cost technical resource hubs in the region to augment the technical development of their solutions.

The ProSpace team is sharp in understanding customer needs, and conscientious in improving the value of its products and services, producing what is required quickly and delivering faster than its competitors. They are the first in the region with this product and service, and are holding their own against more established bigger organisations.

ProSpace has proven IoT solutions and immediate plans to further its reach into the Japanese market, and this exposure through the Asian Entrepreneurship Awards, will benefit them tremendously.

After knowing 70 percent of humanity’s water supply goes toward growing plants, Hugreen decided to make plants production more efficient. Hugreen is a modern agriculture company that develops a solution for flower/delicate plants growers, integrating international resources to develop a precise and automated managing system. Automated facilities, irrigation, temperature controller, and lightening systems are controlled by precision agriculture sensors.
A cloud base plant library recommends the optimum conditions for different types of plants. Sensor-database cross comparison system prevents all diseases and pests beforehand by showing the alarm/recommendations to customer’s smart phone. The flexibility, accuracy and price over performance ratio let us receive more than 10000 sets preorders from Australia, north America, and Europe. Hugreen dedicate ourselves to help small farmers also can grow better and save more resources.

Founder & CEO

Nominated by

Graduate Institute of Technology, Innovation & Intellectual Property Management National Chengchi University
Hugreen is a pioneer in the area of IoT for agriculture. It provides solutions for the efficiency of agricultural farming to address waste of resources and cost of farm management. Hugreen not only provide solutions for crops, it also ultimately solve farming problems and food shortages under climate change and resources limitation.

Our mission
Neurobit is dedicated to providing a solution — A portable, wireless, eye movement/ nystagmus recording and analysis device (Neurospeed). When the medical imaging database established via artificial intelligence, we can make early detection and prediction to prevent the stroke and other brain diseases.

Company and management
Neurobit is headquartered and incorporated in Taipei City. The management of Neurobit consists of co-owners is listed below:

Name Title Background Speciality
Travis Yang CEO NTU-MSE PhD Biomedical Engineering and Biomaterials Design
Roger Chen COO & CFO FJCU-MGEM Marketing and Management
Jim Huang CTO & CDO NTU-BME MS Industrial and Mechanical Design
Ching-Fu Wang Technical Consultant NYMU-BME PhD Biomedical Data Science Analysis

In addition, we have assembled a board of advisors to provide management expertise. The advisors are:
Tzu-Pu Chang, M.D., Department of Neurology, Johns Hopkins University School of Medicine
Ke-Hung Chien, M.D., Oculofacial plastic and Orbital surgery, Ophthalmology, UCI Health Gavin Herbert Eye Institute
Tzu-Ming Liu, Ph.D., Associate Professor, Faculty of Health Sciences, University of Macau Chun-Yi Huang, Ph.D., Former TFDA Supervisory Medical Technologist

Our services
* Rapid Screening of Stroke and Brain Diseases
* Classification of Nerve Diseases
* Pre-treatment Evaluation & Post-treatment Monitoring


Nominated by

Graduate Institute of Technology, Innovation & Intellectual Property Management National Chengchi University
Neurobit is a pioneer in the field of medical diagnosis, which is an artificial intelligence system for stroke detection at very early stage, and to prevent many brain-related diseases. Stroke and brain diseases are missing effective methods for diagnosis and prevention. Such issues consume huge medical resources and cost. Neurobit develops a novel neuron detection method with artificial intelligence technology to diagnose the risk of stroke at the early stage, which will greatly reduce social costs and improve the quality of life.

33 million people around the world are suffering from irregular heartbeats and expecting to increase 5 million more annually due to aging population. Thailand and many countries globally are become aged society. Irregular heartbeats increases 5x risk of stroke. By 2021, 1 million out of 13.1 million people of aged population are at risk in Thailand. Early detection of irregular heartbeats or Atrial Fibrillation (“AFib”) can save lives. However, an early detection of AFib is limited due to lack of accessible to affordable devices. Hear Diary intends to solve this problem by providing a remote patient monitoring platform together with disposable patch. So, we can solve the affordability of devices as well as reduce cost of care for patients.

Unique features of Heart Diary is FDA approved ECG patch that is thinner and lighter than all FDA approved patches available on the market. This reduce restrictions that imposed by traditional Holter monitoring. Pay-Per-Screening business model allows care provider to focus on providing service and less worry about procuring the devices.

Heart Diary is interested in providing service to Japanese. We aim to collaborate with Japanese care providers to service 72,754 Japanese in Thailand and extend globally.


Nominated by

Program Director,
Innovation Driven Entrepreneurship Center
This service addresses an important part of the trend of aging societies found in Japan and across Asia. Personalized medicine (in this particular case, personalized heart monitoring) offer opportunities for people who are living longer lives to also live happier lives. The market opportunity is suitable for Thailand, where this company has been launched; in Japan, which also has an aging society; and in combined market opportunities such as longstay and medical tourism from Japan to Thailand, another important trend.

The technology and product have undergone initial tests and now the team is focusing on developing the appropriate service and customer development model. The underlying technology is proprietary and held in a close partnership among three technology suppliers.

The team is headed by an accomplished technologist with significant business experience across Asia in related technologies, and other members of the team are experts in medicine, including holistic medical practices. Partners include the manufacturer of the underlying monitoring chip, the manufacturer of the heart monitor and communication system, and a large medical group in Thailand.

• Large market with a clear, important problem.
• A tested technology and product which has undergone initial pilot development.
• A seasoned team and important partners.

Abivin provides intelligent software for enterprises. Our team includes the world’s top algorithmic engineers, alumni of top universities around the world and global tech companies (Cambridge, Google). Our core strength is big data analytic, AI, IoT, smart algorithms and optimization. We develop Abivin vRoute, an AI-powered Logistics Optimization Solution with proprietary route optimization algorithm, helping customers like P&G, FrieslandCampina, A.O.Smith, Habeco, KOSPA Logistics save 30% logistics costs, increase productivity, digitize end-to-end delivery process, and improve management efficiency. Combining distinctive features of an Inventory Management, Transport Management and Route Optimization software, it is the most comprehensive platform for every logistics function.

CEO & Founder

Nominated by

Foreign Trade University
- Frontier tech startups in Vietnam with a proven traction, financed by Innovation Partnership Program by Vietnam and Finland government.

- Abivin is expanding rapidly in ASEAN, with current presence in Vietnam, Singapore, Myanmar, and Indonesia.

- The founding team are outstanding, and have a very strong technical background. The CEO is MA in Computer Science from Cambridge, MSc in Machine Learning from Bristol, was a serial medalist in international olympiad in informatics, maths, physics, was working at Google in Silicon Valley before starting Abivin.